chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 3/15/02, arm red and hive-like, hot to touch, localize, 3" in diameter. Legs and thighs felt achy. On 3/20/02, to ER because of increasing pain and loss of mobility in legs. Treated and discharged but on anti-inflammatories. On 3/31/02, to different ER and admitted. Symptoms were worse. Also had swelling on thighs and knee. Partially full recovery in one month. Transferred to a larger hospital. Hospitalized on 4/3/02. Concerned that she had rheumatoid arthritis or Guillain-Barre. Did pain control. Now doing stretching exercises. Symptoms were pain and decreased strength. Had flu-like symptoms on 3/16/02 and URI symptoms. Was given Z-pack on 3/28/02 for URI symptoms. Did tell doctor about leg symptoms. Did huge battery of test, X-rays and MRI's at another hospital. Fever to 100F X 1 day. On 3/12/02 after injections into occipital area for pain of migraine headache. Now on Vioxx, Vitamin B and ice seems to help. The follow up received on 4/17/02 states, "out chart lists pt as having an allergy to Erythromycin. It does not state how she reacts. pt was given 2 pack on 3/28/02."
Extreme itching from head to toe. Itchy throat and ears. It?s exactly what happens when I ingest soy. I have been itching like this for 5 days now. May go to drs. If it doesn?t start to get better. Polyethylene glycol is derived from soy and should be mentioned for people who have soy allergies. I am very careful about avoiding Soy and after my symptoms began I knew I didn?t ingest it. That?s when I put the 2 together. Luckily my soy allergy is not life threatening, but some people?s may be.
Patient was scheduled to received the 2nd Moderna Vaccine, but instead received the Pfizer vaccine.
9 days after vaccine, a new red skin rash appeared  at site of injection.   Approximately 3" diameter. No visible blisters.  Arm sore. Itching and burning like a wasp sting.  Used topical caladryl lotion to no effect.  Took Benadryl / Diphenhydramine which reduced the itching.
This case was reported by a consumer via call center representative and described the occurrence of fever in a 57-year-old female patient who received Shingrix for prophylaxis. On 16th May 2018, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 17th May 2018, 1 days after receiving Shingrix, the patient experienced fever, pulse rapid, headache, dizziness, nausea, stomach pain and chest pain. On an unknown date, the outcome of the fever, pulse rapid, headache, dizziness, nausea, stomach pain and chest pain were recovered/resolved. It was unknown if the reporter considered the fever, pulse rapid, headache, dizziness, nausea, stomach pain and chest pain to be related to Shingrix. Additional details were provided as follows: The patient received Shingrix on left arm. The patient reported that, she experienced fever (the patient's body temperature was recorded as 101.4 degree F) and pulse went as high as 119 beats per minute. The patient planned to continue follow-up with her pharmacist on an unknown date.
Splotches; Rash; Lots of itching; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Splotches), RASH (Rash) and PRURITUS (Lots of itching) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (Splotches), RASH (Rash) and PRURITUS (Lots of itching). At the time of the report, RASH MACULAR (Splotches), RASH (Rash) and PRURITUS (Lots of itching) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable. No concomitant medication was mentioned. Treatment medication mentioned is Cortisone cream.
About 12 hours after I received the vaccine I awoke with a fever of 105F, chills, and achiness.  The 105F fever lasted for 2 days, then decreased to 102F for another 2 days.  Finally on the 5th day following the vaccine I began to feel better.
Moderna administered to patient less than 18 years old (i.e. 17 years old).
she recieved 3 shots..the MMR, IPV and chicken pox..she was given 2 shots in 1 leg and the 3rd in a different leg..the leg that had 2 shots in it is swollen like the size of my palm of my hand.no fever..just swollen and red
Directly after giving HPV injection, patient appeared to have possible seizure lasting approximately 3 seconds with quick body stiffening and eye witches, then immediately went acid. Immediately placed patient on right side and monitored for 30 minutes. Vital signs assessed and within normal limits x2.
Tachycardia (heart rate 103- 111) for more than 12 hours
No additional adverse events reported; children received 2nd dose of VAQTA but it was the adult dosage not pediatric; This spontaneous report was received from a pharmacist intern referring to a 6 years old patient of unknown gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.      On 30-AUG-2021 (yesterday), the patient was vaccinated with the second dose of hepatitis a vaccine, inactivated (VAQTA) (adult dose; strength, dose, route of administration, anatomical location, lot# and expiration date were not reported) for prophylaxis (incorrect dose administered). No additional adverse events reported. No product quality complaints.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2109USA000316:
The symptoms began after the second dose of the Moderna vaccine. I experienced a fever in of nearly 104 degrees, which lasted for about 36 hours. I was too weak to move from bed until about 48 hours after the vaccination. Beginning 2 days after vaccination once I could move again, I started to experience episodes of periodic profound fatigue, usually lasting only a day or two at a time, usually following minor exertion (such as gardening, paddle boarding,  painting, for example).  Then, about 2 months after the 2nd dose, I suddenly became much worse. The fatigue became constant, and I could no longer stand without becoming dizzy and my heart feeling like it would beat out of my chest.  Even driving was too much, as blood would pool in my arms and legs.  I had recurring headaches, digestive problems that came out of nowhere. These symptoms started to get better in August, very gradually. I was diagnosed with POTS in September after tilt table test. I received a Pfizer booster in October at the recommendation of my cardiologist, who believed that covid posed a greater risk than the side effects from the vaccine. The symptoms again worsened.
Experienced increasing shortness of breath and tested COVID positive around 12/26/2021.  Required hospitalization because of increasing hypoxia  on 1/2/2022. Transitioned to hospice care on 1/11/2022.  ARDS and CRT>
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Nov2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 32 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Multiple sclerosis and currently receiving B-cell depleter for treatment" (unspecified if ongoing), notes: currently receiving B-cell depleter for treatment; "Known allergies: Soy" (unspecified if ongoing); "Known allergies: tree nuts" (unspecified if ongoing); "Known allergies: pollen" (unspecified if ongoing); "Known allergies: animals" (unspecified if ongoing). There were no concomitant medications.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "recovered" (2022) and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 06Dec2022 to 11Dec2022. Clinical course: The lot number misplaced/discarded.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Body aches, numb/tingling face, weakness, Fatigued, diarrhea
Patient was administered a 4th dose of 0.25 ml. Patient had already received 0.25ml booster dose in Nov 2021
After first 12 hrs:  headache (migraine like) for 10-12 hrs After fist 30-36hrs:  increase local pain at site on injection, some muscle pain on the arm, numbness on upper lip, chills without fever 3rd-4th  days post vaccine:  no headache, extreme pain to light skin touch at the site of infection and muscle pain (significant more after rest; after arm was not being used for a while);  lip numbness had gone away x 24 hrs and came back 6-7th day post vaccine:  tender enlarged nodes on left axilla (same arm of injection) with some mild tenderness on arm movement and light upper lip numbness.
09/11/2011 Earache and pain on right side of head. 09/12/2011 Went to family doctor, no treatment minor swimmers ear diagnosed 09/18/2011 Right side Facial muscles lose control.  Cannot smile, close right eye, and problems drinking with out slobbering.   Visited ER and was diagnosed with Bell's palsy or Ramsey Hunter syndrome II.   Additional I had Oral Surgery on 9/14/2011 to remove #1 wisdom tooth.
Patient had very swollen hands from the wrist down but no other symptoms. Had bad pain. The patient had this on the first vaccine too after a couple days of receiving the vaccine. After the doctor checked it out after the first vaccine, he tested for gout and arthritis but it came back negative. This has only flared up after receiving both Shingrix doses several days after.
Information has been received from a physician concerning a 7 year old white male with no known allergies or past medical history who on 10-FEB-2000 was vaccinated SC with a 0.5 ml first dose of Varivax (lot# "1305J-M"). There was no concomitant medication. On 26-JUN-2006 the patient experienced a "breakthrough rash of 50 or more lesions" of chicken pox. Unspecified medical attention was sought. On 11-JUL-2006 the patient recovered. There was no product quality complaint involved. Additional information is not expected.
Pfizer vaccine was diluted with NS 0.9% Bacteriostatic which is not recommended for use with this vaccines. Reported to Pfizer and CDC. As per recommendation from CDC, affected dose should be repeated. Made multiple attempts to reach the parent of the pt without success. Message was left to discuss the need to repeat pt's 1st dose.
Leg pain resulting in a DVT in the left popliteal vein 10 days after 1 vaccine given to patient.
Injection site swollen, upper arm at injection site itching, tired approximately  2 days after vaccination. Experiencing upper respiratory problems such coughing, congestion since injection but could be high outdoor allergies
Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
mRNA-1273 treatment under Emergency Use Authorization(EUA): Patient received first dose of Moderna Covid vaccine at about 10:30 on 1/4/21. Experienced body aches and low grade fever throughout the night of 1/4/21 and continued with body aches most of day on 1/5/21. Felt fine again morning of 1/6/21.
Soreness & itch in left arm at shot site. The following night the arm was bright red, swollen & extremely itchy.  The following morning went to the Urgent care clinic.  Was seen & examined, the arm was measured at 18cm from side to side. Was given a prescription for Cephalexin 500MG to take for 7 days.  Started pills on that day, by the 3rd day the redness was starting to fade. Completed the course of pills , the itching stopped & arm slowly went back to normal
Red rash lateral aspect (R) thigh ~ 5mm x 3mm in size = Red, warm to touch Possible fever which resulted (secondarily) in a febrile seizure = initially seen @ ER by ambulance & F/U @ Dr. Office
She had no adverse events after her Pfizer Covid vaccine on 12/18/20 or 1/8/21.  She did become pregnant with a LMP of 1/10/21 and a confirmed EDC of 10/17/21.  She had symptoms and tested positive for Covid on 5/2/21.  She states that her test was a rapid test that was done with her employee health.   She had mild symptoms with congestion, loss of taste and smell.  She has recovered and fetus is doing well as of 5/18/21.
pt recv vax & devel swelling, redness & warmth in rt deltoid of vax;pt recovered;this is 1 of 4 pt from this site to devel an inj site rxn p/vax;
Patient felt dizzy and we made the patient lie down on her back and elevated her feet. She fainted for few seconds and was back to normal in couple of seconds.. we applied cold compress on her face, neck and wrist. Observed her more than 45 minutes
Within minutes of receiving vaccines, reported dizziness/light-headed feeling; not relieved by lying supine.  Sxms progressed over next 30 min to included CP, SOB, tingling/stiffness in jaw and arms, and slurred speech.  No specific globus, swelling, urticaria, or other skin changes.  Transported to ER and given only Benadryl; no epi.  Sxms resolved over approx 2 hrs of observation.  ER dxd "acute anxiety with hyperventilation."  Subsequent consultations were made to Allergy/Immunology, Psychiatry, and DHA Immunization Healthcare team.
Patient was 17 years of age when vaccine was administered. Vaccine approved for 18 years of age and older. Patient did not experience any adverse reactions.
Approximately 5 minutes after administration of the covid-19 vaccine, the patient became dizzy/light headed. The patient laid down in the vaccination room, where we provided water, ice, and an epi-pen at stand by. patient became red in the face and stated she had difficulty breathing. Upon obstervation, she was also very clammy and shaking. After 30 minutes, patient stated she was starting to be unable to breathe and was nauseous, upon request by her and the patient's mother, an Epi-pen was adminitestered by myself, and the mother felt comfortable taking the patient to the hospital a few minutes later for observation. A second epi pen was not requested/needed/administered at our facility.
PATIENT CAME IN 11/10/2015 PRESENTING REDNESS, SWELLING AND STIFFNESS ON THE ARM WHERE SHE RECEIVED IMZ (BOOSTRIX AND FLUVIRIN). I RECOMMENDED SHE VISIT NEARBY URGENT CARE FACILITY.
Eight hours after the shot, I quickly became very chilled with total body aches and pains and extremely tired.  My mouth became very dry.  This lasted most of the night.  The next morning approaching 24 hours after the shot, the initial side effects were gone but I then had a headache and a bit of nausea.  Again was extremely tired and pretty much rested all day.  All side effects were gone the next day.  I felt no need to call my healthcare provider and did not take any over the counter pain medication.
On 06/02/2021, (23 days after vaccine) the patient and his identical twin brother were at dinner when patient had shortness of breath and chest pain.  They brought the patient to Medical Center where a CT of the chest was performed to rule out a pulmonary embolus.   No pulmonary embolus  was identified and patient was transferred the patient via ambulance to  Hospital to the intensive care unit.  He was noted to have an elevated troponin, an elevated BNP and a left ventricular ejection fraction of 35%. He underwent a cardiac MRI on 06/04/2021 documenting delayed enhancement in the inferior and inferolateral walls of the left ventricle consistent with myocarditis.  The patient's chest pain was quite severe and was only relieved once he was in the intensive care unit at Hospital.  He did well for 2-3 days and did not require inotropes but his troponin vacillated and his ejection fraction remain low.  He was given IVIG non 06/05/2021 after his echo showed an ejection fraction between 37 in 45%. He subsequently developed headache emesis and neck pain.   On hospital day 5, the father was quite concerned for his son and thought ?he was going to die?.   The father shared pictures of the edematous, pale son that he took with his phone. He improved over the next 1-2 days and was discharged from the hospital with an ejection fraction on 06/07/21 of 62%.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Additional Details: advised patient to try benadryl
Information has been received from a consumer and a nurse concerning an approximately 12 month old male who on 05-MAR-2010 was vaccinated with a dose of VARIVAX (Merck). On 17-MAR-2010, the patient did have a rash on his side. On 12-APR-2010, the rash had likely healed. Additional information is not expected. A 15 year old female who babysat the patient experienced secondary transmission and chickenpox. The events has been captured in WAES 1004USA00190.
I had symptoms of  low level un-diagnosed kidney infection for about a month prior to getting the Covid booster vaccine.   About a day after getting the vaccine, the kidney infection significantly  increased, I started having spots of blood come out of my urine tract, had a fever of 102.6 F for a couple days before my wife convinced me to go the the clinic.   They diagnosed it , gave me antibiotics  and it quickly cleared up.  The booster seems to have triggered the infection to get significantly  worse.
Employee reported reaction today at around 3pm on 04/22/2002 with lightheadedness, dizziness, pain in both knees and ache in both quadriceps, extreme nausea, some SOB. No rash and no SOB on 04/23/2002.
About 6 days after receiving the first dose of the Moderna vaccine, he started to develop a bitter, metallic taste in his mouth. The morning of the effect, he felt fine and had no other symptoms until approximately 4:50 pm where water tasted odd to him. Before the vaccine, he had no other covid symptoms and has tested negative for the virus numerous times. This only occurred after receiving the Moderna shot.
Child developed a red, spotted itch rash on his torso and both arms from wrists to shoulders. His pediatrician ordered oral Benadryl and a topical cortisone cream.
The patient described burning sensation as the vaccine was going in followed by numbness of the right arm and start of a migraine on the same side.  The patient was told to put ice pack on the arm.  The arm seemed to be experiencing localized injection site reaction.  She was informed to take acetominophen when arriving at home and ibuprofen later to help with pain and inflammation
walking caused her to limp; left hip pain appeared localized to left greater trochanteric area with moderate to severe increasing intensity/Pain continued and ongoing, radiation to left anterior thigh and knee/; Pain continued and ongoing for 7 days till 28Apr2021, radiation to left anterior thigh and knee; point tenderness on left greater trochanteric projection; This is a spontaneous report from a contactable physician (patient). A 74-years-old female non-pregnant patient received BNT162b2 (Pfizer BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number: ER8727 and Expiration date was not reported) via an unspecified route of administration, administered in left arm on 14Apr2021 at 08:00 hours as dose 1, single for COVID-19 immunization. Medical history included chronic left low lumbar back pain, minimal prior to vaccination day. Patient had no known allergies. The patient's concomitant medications were not reported. Patient was not diagnosed with COVID-19, prior to vaccination and had not been tested for COVID-19, post vaccination. Patient had no other vaccine in four weeks. On 21Apr2021 at 07:00 hours, 7th day after Pfizer vaccination, patient experienced left hip pain appeared localized to left greater trochanteric area with moderate to severe increasing intensity, (no pain on my usual left lumbar), pain continued and ongoing for 7 days (28Apr2021), radiation to left anterior thigh and knee, point tenderness on left greater trochanteric projection. At height of pain (28Apr2021), walking caused her to limp from pain. Therapeutic measures were taken as a result of events and some relief with oral ibuprofen maximum 600-800 mg per dose with reduced interval as week went by from frequency of every 6 to 4 hours. Temporary relief with additional supplement of patch analgesic & warm compress. Patient continued to self-medicate if needed and will request postponement of second dose on 05May2021 to 28th week depending on her recovery. The outcome of limping was unknown and outcome of rest of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
ER called and stated child had seizure last night. No prior Hx of seizures. Had 6 mo shot yesterday.